On Feb 17, 2026, MED reported earnings of -1.65 USD per share (EPS) for Q4 25, missing the estimate of -0.82 USD, resulting in a -99.23% surprise. Revenue reached 75.10 million, compared to an expected 74.54 million, with a 0.75% difference. The market reacted with a -0.83% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 2 analysts forecast an EPS of -0.52 USD, with revenue projected to reach 69.89 million USD, implying an decrease of -68.48% EPS, and decrease of -6.93% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
SunOpta, Inc.
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.02
Actual
$0.06
Surprise
+123.05%
B&G Foods, Inc.
Report Date
Mar 03, 2026 For Q4 25
Estimate
$0.30
Actual
$0.28
Surprise
-7.59%
The Campbell's Company Common Stock
Report Date
Mar 11, 2026 For Q2 26
Estimate
$0.57
Actual
$0.51
Surprise
-10.87%
United Natural Foods Inc
Report Date
Mar 10, 2026 For Q2 26
Estimate
$0.51
Actual
$0.62
Surprise
+20.13%
FAQ
What were Medifast, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Medifast, Inc. reported EPS of -$1.65, missing estimates by -99.23%, and revenue of $75.10M, 0.75% above expectations.
How did the market react to Medifast, Inc.'s Q4 2025 earnings?
The stock price moved down -0.83%, changed from $10.80 before the earnings release to $10.71 the day after.
When is Medifast, Inc. expected to report next?
The next earning report is scheduled for Apr 27, 2026.
What are the forecasts for Medifast, Inc.'s next earnings report?
Based on 2
analysts, Medifast, Inc. is expected to report EPS of -$0.52 and revenue of $69.89M for Q1 2026.